Compugen (CGEN) Asset Utilization Ratio (2009 - 2026)
Compugen (CGEN) reported Asset Utilization Ratio of 0.48 for Q1 2026, up 100.66% on a YoY basis from 0.24 in Q1 2025, and down 16.0% sequentially from 0.57 in Q4 2025.
Compugen (CGEN) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 14 years of Asset Utilization Ratio data on file, last reported at 0.48 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio rose 100.66% year-over-year to 0.48; the trailing twelve-month figure through Mar 2026 stood at 0.48 (up 100.66% YoY), and the FY2025 full-year result was 0.54, up 127.26% from the prior year.
- Asset Utilization Ratio declined to 0.48 in Q1 2026, from 0.57 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.57 in Q4 2025 to a low of 0.07 in Q3 2025.
- A 5-year average of 0.34 and a median of 0.39 in 2024 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio soared 154.36% in 2023 and slumped 86.81% in 2025, its largest moves.
- Tracing CGEN's Asset Utilization Ratio over 5 years: stood at 0.18 in 2022, then jumped by 154.36% to 0.45 in 2023, then slumped by 48.62% to 0.23 in 2024, then jumped by 144.82% to 0.57 in 2025, then slipped by 16.0% to 0.48 in 2026.
- Business Quant data shows CGEN's Asset Utilization Ratio at 0.48 in Q1 2026, 0.57 in Q4 2025, and 0.07 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | 0.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.48 |
| Dec 31, 2025 | 0.57 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 0.20 |
| Mar 31, 2025 | 0.24 |
| Dec 31, 2024 | 0.23 |
| Sep 30, 2024 | 0.51 |
| Jun 30, 2024 | 0.45 |
| Mar 31, 2024 | 0.39 |
| Dec 31, 2023 | 0.45 |
| Dec 31, 2022 | 0.18 |
| Dec 31, 2020 | 0.07 |
| Dec 31, 2018 | 0.15 |
| Sep 30, 2018 | 0.16 |
| Dec 31, 2016 | 0.01 |
| Sep 30, 2016 | 0.11 |
| Jun 30, 2016 | 0.10 |
| Mar 31, 2016 | 0.09 |
| Dec 31, 2015 | 0.09 |
| Sep 30, 2015 | 0.08 |